{"prompt": "['Novartis', 'Confidential', 'Page 6', 'Amended Protocol Version v02/Clean', 'Protocol No. CQVM149B2306', 'List of abbreviations', 'ACQ-7', 'Asthma Control Questionnaire-7', 'AE', 'Adverse Event', 'ALT', 'Alanine Aminotransferase', 'ANCOVA', 'Analysis of covariance', 'AQLQ(S)', 'Asthma Quality of Life Questionnaire', 'AST', 'Aspartate Aminotransferase', 'ATS/ERS', 'American Thoracic Society/European Respiratory Society', 'BMI', 'Body Mass Index', 'BPH', 'Benign prostatic hyperplasia', 'b.i.d.', 'twice a day', 'CCV', 'Cardiovascular and Cerebrovascular', 'CFR', 'US Code of Federal Regulations', 'COPD', 'Chronic Obstructive Pulmonary Disease', 'CPO', 'Country Pharma Organization', 'CRF', 'Case Report/Record Form (paper or electronic)', 'CRO', 'Contract Research Organization', 'DALYs', 'Disability- Adjusted Life Years', 'DAR', 'Dose Administration Record', 'DPI', 'Dry Powder Inhaler', 'ECG', 'Electrocardiogram', 'EDC', 'Electronic Data Capture', 'EMA', 'European Medicines Agency', 'ER', 'Emergency Room', 'EU', 'European Union', 'FAS', 'Full analysis set', 'FDC', 'Fixed dose combination', 'FEF25-75', 'Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity', 'FEV1', 'Forced Expiratory Volume in 1 second', 'FVC', 'Forced Vital Capacity', 'GCP', 'Good Clinical Practice', 'GEE', 'Generalized estimating equation', 'GINA', 'Global Initiative for Asthma', 'GLI', 'Global Lung Function Initiative', 'GGT/yGT', 'Gamma Glutamyl Transferase', 'gMCP', 'Graph Based Multiple Comparison Procedures', 'HCP', 'Health Care Practitioner', 'ICH', 'International Conference on Harmonisation of Technical Requirements for', 'Registration of Pharmaceuticals for Human Use', 'IB', 'Investigator Brochure', 'ICS/LABA', 'Combination of inhaled corticosteroid and long acting beta agonist', 'IEC', 'Independent Ethics Committee']['Novartis', 'Confidential', 'Page 7', 'Amended Protocol Version v02/Clean', 'Protocol No. CQVM149B2306', 'IgE', 'Immunoglobulin E', 'IM', 'Intramuscular', 'IRB', 'Institutional Review Board', 'IRT', 'Interactive Response Technology', 'IUD', 'Intrauterine device', 'IUS', 'Intrauterine system', 'IV', 'Intravenous', 'LABA', 'Long-acting \u00df adrenoceptor agonists', 'LAMA', 'Long Acting Muscarinic Antagonist', 'LFT', 'Liver function test', 'LTRA', 'Leukotriene receptor antagonists', 'MCID', 'Minimal important difference', 'MDI', 'Metered dose inhaler', 'MedDRA', 'Medical Dictionary for Regulatory Activities', 'MMRM', 'Model for repeated measure', 'NI', 'Non-inferiority', 'OCS', 'Oral corticosteroid', 'OC/RDC', 'Oracle Clinical/Remote Data Capture', 'o.d.', 'once a day', 'PEF', 'Peak Expiratory Flow', 'p.o.', 'oral(ly)', 'PPS', 'Per protocol set', 'PRO', 'Patient Reported Outcome', 'QoL', 'Quality of Life', 'SABA', 'Short Acting \u00df2 Agonist', 'SAE', 'Serious Adverse Event', 'SAMA', 'Short acting anticholinergics', 'SAP', 'Statistical analysis plan', 'SCS', 'Systemic corticosteroid', 'SDDPI', 'Single dose dry powder inhaler', 'SUSAR', 'Suspected Unexpected Serious Adverse Reactions', 'TBL', 'Total bilirubin', 'TD', 'Treatment Discontinuation', 'ULN', 'Upper limit of normal', 'WHO', 'World Health Organization', 'WoC', 'Withdrawal of Consent']\n\n###\n\n", "completion": "END"}